{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:36:56Z","timestamp":1790681816483,"version":"4.1.0"},"reference-count":34,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T00:00:00Z","timestamp":1668297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kaohsiung Medical University Hospital","award":["S10905"],"award-info":[{"award-number":["S10905"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Background: How different tools for evaluating health-related quality of life (QoL) reflect the burden of vitiligo has rarely been compared. In this study, we aim to evaluate the impact of vitiligo on QoL using currently available tools. Methods: A single-center, cross-sectional study of vitiligo patients was performed. QoL was evaluated using the dermatology life quality index (DLQI), short form-36 (SF-36), and willingness to pay (WTP). As the original DLQI cutoff score (&gt;10) indicating aginificantly impated QoL was found to underestimate QoL, receiver operating characteristic (ROC) curve was use to determine a new cutoff point discriminating vitiligo patients with positive mental stress (SF-36 mental health \u2264 52). Results: Of the 143 patients enrolled, 24.5% were identified having significant mental stress by SF-36 mental health domain score \u2264 52 while there were only 13.3% patients with significantly hampered QoL indicated by DLQI &gt;10. Using ROC analysis, DLQI \u2265 7 was found to be a more appropriate DLQI cutoff value for identifying mental stress in vitiligo patients. Additionally, the median WTP for treating vitiligo was comparable to other inflammatory skin diseases. Conclusions: There exist discrepancies in the outcomes identifying significant disease burden of vitiligo using DLQI and SF-36, making the current DLQI cutoff score (&gt;10) for identifying significantly affected QoL inappropriate for these patients.<\/jats:p>","DOI":"10.3390\/ijerph192214943","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T02:32:01Z","timestamp":1668393121000},"page":"14943","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of Vitiligo on Life Quality of Patients: Assessment of Currently Available Tools"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9515-5336","authenticated-orcid":false,"given":"Ting-Ting","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan"},{"name":"Department of Dermatology, Pingtung Hospital, Ministry of Health and Welfare, Pingtung 900, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0988-264X","authenticated-orcid":false,"given":"Chien-Hung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 807, Taiwan"},{"name":"Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Che E.","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan"},{"name":"Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1473-2165.2008.00384.x","article-title":"Prevalence of pigmentary disorders and their impact on quality of life: A prospective cohort study","volume":"7","author":"Taylor","year":"2008","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_2","first-page":"1330","article-title":"Vitiligo","volume":"Volume 1","author":"Kang","year":"2019","journal-title":"Fitzpatrick\u2019s Dermatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.det.2011.11.013","article-title":"Quality-of-life issues in vitiligo","volume":"30","author":"Bhandarkar","year":"2012","journal-title":"Dermatol. Clin."},{"key":"ref_4","first-page":"19","article-title":"Frequency and pattern of psychiatric disorders in patients with vitiligo","volume":"19","author":"Ahmed","year":"2007","journal-title":"J. Ayub. Med. Coll. Abbottabad."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1365-2702.2011.03777.x","article-title":"Investigating factors associated with depression of vitiligo patients in Singapore","volume":"21","author":"Chan","year":"2012","journal-title":"J. Clin. Nurs."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: What do dermatology life quality index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2014A simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chernyshov, P.V., Tomas-Aragones, L., Manolache, L., Pustisek, N., Salavastru, C.M., Marron, S.E., Bewley, A., Svensson, A., Poot, F., and Suru, A. (2022). Quality of life measurement in vitiligo. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes with external experts. J. Eur. Acad. Dermatol. Venereol., ahead of print.","DOI":"10.1111\/jdv.17370"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.dsi.2016.05.004","article-title":"Health state utility, willingness to pay, and quality of life among Taiwanese patients with psoriasis","volume":"34","author":"Ko","year":"2016","journal-title":"Dermatol. Sinica."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2133.1999.03207.x","article-title":"Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema","volume":"141","author":"Lundberg","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2012.50","article-title":"Willingness to pay in dermatology: Assessment of the burden of skin diseases","volume":"132","author":"Seidler","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"ref_12","unstructured":"Directorate-General of Budget, Accounting and Statistics, Executive Yuan (2022, November 10). Employees\u2019 Earnings Survey, 2017 (AA220031) [data file]. Available from Survey Research Data Archive, Academia Sinica. Available online: https:\/\/srda.sinica.edu.tw\/datasearch_detail.php?id=2858."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00403-013-1402-1","article-title":"Willingness to pay and quality of life in patients with atopic dermatitis","volume":"306","author":"Beikert","year":"2014","journal-title":"Arch. Dermatol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1468-3083.2012.04549.x","article-title":"Willingness to pay and quality of life in patients with rosacea","volume":"27","author":"Beikert","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: New outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"Taft","year":"2001","journal-title":"Qual. Life Res."},{"key":"ref_17","unstructured":"Ware, J.E., Snow, K.K., Kosinski, M., and Gandek, B. (1993). SF-36 Health Survey Manual and Interpretation Guide, New England Medical Center, The Health Institute."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jid.2015.12.040","article-title":"Development and Validation of the Vitiligo Extent Score (VES): An International Collaborative Initiative","volume":"136","author":"Lommerts","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chin, Y.-T., Lin, W.-T., Wu, P.-W., Tsai, S., Lee, C.-Y., Seal, D., Chen, T., Huang, H.-L., and Lee, C.-H. (2020). Characteristic-Grouped Adiposity Indicators for Identifying Metabolic Syndrome in Adolescents: Develop and Valid Risk Screening Tools Using Dual Population. Nutrients, 12.","DOI":"10.3390\/nu12103165"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","article-title":"Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)","volume":"69","author":"Lilly","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/bjd.13093","article-title":"Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument","volume":"171","author":"Gupta","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/JID.2015.398","article-title":"The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool","volume":"136","author":"Salzes","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chen, D., Tuan, H., Zhou, E.Y., Liu, D., and Zhao, Y. (2019). Quality of life of adult vitiligo patients using camouflage: A survey in a Chinese vitiligo community. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210581"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1473-2165.2010.00479.x","article-title":"Camouflage for patients with vitiligo vulgaris improved their quality of life","volume":"9","author":"Tanioka","year":"2010","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1468-3083.2010.03808.x","article-title":"Health-related quality of life and marital quality of vitiligo patients in China","volume":"25","author":"Wang","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect of vitiligo on self-reported health-related quality of life","volume":"152","author":"Ongenae","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_27","first-page":"57","article-title":"Comparative study of quality of life between psoriasis, vitiligo and autoimmune bullous disease","volume":"25","author":"Xu","year":"2017","journal-title":"Hong Kong J. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10 years experience of the Dermatology Life Quality Index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_29","first-page":"512","article-title":"Assessment of health-related quality of life in Taiwan (II): Norming and validation of SF-36 Taiwan version","volume":"22","author":"Tseng","year":"2003","journal-title":"Taiwan J. Public Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2133.2009.09077.x","article-title":"Objective vs. subjective factors in the psychological impact of vitiligo: The experience from a French referral centre","volume":"161","author":"Kostopoulou","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000246657","article-title":"Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism","volume":"190","author":"Salzer","year":"1995","journal-title":"Dermatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12955-020-1278-7","article-title":"Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population","volume":"18","author":"Hamidizadeh","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bjd.15199","article-title":"Vitiligo and depression: A systematic review and meta-analysis of observational studies","volume":"177","author":"Lai","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jaad.2020.09.088","article-title":"Beyond quality of life: A call for patients\u2019 own willingness to pay in chronic skin disease to assess psychosocial burden-A multicenter, cross-sectional, prospective survey","volume":"85","author":"Bae","year":"2021","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/22\/14943\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:17:24Z","timestamp":1760145444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/22\/14943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,13]]},"references-count":34,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijerph192214943"],"URL":"https:\/\/doi.org\/10.3390\/ijerph192214943","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,13]]}}}